Relevant presentations, workshops and posters by current and former members of the StarDrop team. Take a look at the community pages to see copies of the various publications and presentations we've published.
Presentations
- Guided Application of Med Chem Rules to Generate 'Good' Ideas
Segall, MD
ACS Spring Meeting, March 2011, Anaheim, CA, USA - Making Priors a Priority
Segall, MD
ACS Spring Meeting, March 2011, Anaheim, CA, USA - Automatically Finding Drug Discovery 'Rules of Thumb'
Tatsunori Hashimoto, Matthew Segall and Ed Champness
Euro QSAR, September 2010, Rhodes, Greece - Exploring Project Spaces to Quickly Identify High Quality Compounds
Champness EJ, Segall MD
MipTec, September 2010, Basel, Switzerland - Finding drug discovery "rules of thumb" with bump hunting
Mr. Tatsunori Hashimoto, Dr. Matthew Segall PhD.
ACS Fall Meeting, August 2010, Boston, MA, USA - Psychological barriers to good decision-making: How addressing cognitive biases could improve drug discovery
Segall MD, Chadwick A
ACS Spring meeting, March 2010, San Francisco, CA, USA - Visual analyses for guiding compound selection and design
Champness EJ
ACS Spring meeting, March 2010, San Francisco, CA, USA - Guiding the Decision-Making Process to Identify High Quality Compounds
M.D. Segall, E. Champness, O. Obrezanova, C. Leeding
ISSX North American meeting, October 2009, Baltimore, USA - Enabling Interactive Multi-Objective Optimization for Drug Discovery Scientists
Champness EJ
BeLive IT, October 2009, Brussels, Belgium - Drug discovery - Why gamble when you can count cards?
Champness EJ
Bio-IT World Europe, October 2009, Hannover, Germany - BioInformatics and Drug Discovery-"StarDrop" Drug Discovery Platform
Segall MD
Tennessee Biotechnology Association, September 2009, Nashville, TN, USA - Automated QSAR Modeling to Guide Drug Design
Obrezanova O, Segall MD
ACS National Meeting, Spring 2009, Salt Lake City, UT, USA - Automated QSAR Modeling to Guide Drug Design
Obrezanova O, Segall MD, Gola JMR, Champness EJ
Zing Computational Chemistry Meeting, March 2009, Antigua - Automatic QSAR Modeling of Blood-Brain Barrier Penetration by Gaussian Processes Method
Obrezanova O, Gola JMR, Champness EJ, Segall MD
eCheminfo Latest Advances in Drug Discovery Informatics, October 2008, Philadelphia, PA, USA - Multiparameter Optimisation: Achieving Balance with Confidence
Segall MD
MipTec, October 2008, Basel, Switzerland - ADMET Optimization and in Silico Drug Discovery
Segall MD
IBM Life Sciences Modeling & Simulation Summit, September 2008, Amagi Homestead, Japan - Turning uncertain, multivariate data into effective decisions
Segall MD
AAPS Drug Discovery Strategies and Critical Issues for Clinical Candidate Selection, May 2008, South San Francisco - From Drug Discovery to Drug Design: Uncertain models to certain success?
Segall MD
ADMET Europe, February 2008, Stockholm, Sweden - From Drug Discovery to Drug Design: Uncertain models to certain success?
Segall MD
ACS Western Regional Meeting, October 2007, San Diego, CA, USA - Gaussian Processes: A method for automatic QSAR and ADME modelling
Obrezanova O, Gola J, Segall M
ACS Fall Meeting, August 2007, Boston, MA, USA - Predictive ADME Models in Drug Discovery: Can You Trust Them? Can You Afford Not To?
Beresford A
Med Chem USA, October 2007, Boston, MA, USA - Gaussian Processes: A method for automatic QSAR and ADME modelling
Obrezanova O, Gola J, Segall M
UK QSAR, October 2007, Stevenage, UK - Automatic Model Generation.
Gola JMR, Obrezanova O
4th Joint Sheffield Conference on Chemoinformatics, June 2007, Sheffield, UK - The Journey from Drug Discovery to Drug Design: How far have we travelled?
Segall MD
SMI in Silico ADMET, May 2007, London, UK - Opening the "black box": Interpreting in silico models to guide compound design.
Champness E
ACS Spring Meeting, March 2007, Chicago, IL, USA - Why are we Still Doing Drug Discovery?
Segall MD
ACS Spring Meeting, March 2007, Chicago, IL, USA - ADME Screening: High Throughput vs High Intelligence.
Beresford AP
Med Chem Europe, February 2007, Barcelona, Spain
Workshops
- Olga Obrezanova lead a session on Building QSAR models to Guide Drug Design at the Predictive ADME and Toxicology Workshop.
eCheminfo, 27th-31st July 2009, Oxford, UK - Matt Segall presented a session titled Enabling Interactive Multi-Objective Optimization for Drug Discovery Scientists at the Lorentz Workshop - Optimizing Drug Design, 21st-23rd July 2009, Lorentz Centre, Leiden, The Netherlands
Posters
- Predicting Regioselectivity and Lability of Cytochrome P450 Metabolism using Quantum Mechanical Simulations
Segall MD
ISSX, October 2011, Atlanta, GA, USA - Automatic Generation and Validation of QSAR Toxicity Models
Segall MD
ISSX, October 2011, Atlanta, GA, USA - Maximising compound value by making good decisions: How addressing cognitive biases could improve drug discovery
Segall MD, Chadwick A
MipTec, September 2010, Basel, Switzerland - Guiding Focused Design of Potent Leads with Improved Metabolic Stability
Matthew Segall
ISSX, September 2010, Istanbul, Turkey - Automatically Finding Drug Discovery 'Rules of Thumb'
Tatsunori Hashimoto, Iskander Yosuf, Matthew Segall, Ed Champness
ISSX, September 2010, Istanbul, Turkey - Application of in Silico (ADMEnsa Interactive) and ADME/PK Assays in the Identification of New Chemical Entities(NCEs) for Pre-Clinical Evaluation
McCormick D, Champness E, Gola J
ISSX, October 2007, Sendai, Japan - Opening the 'Black Box': Interpreting in Silico Models to Guide Compound Design.
Segall MD, Champness E
Med Chem Europe. February 2007, Barcelona
